Lori Reiman

Lori Reiman has a strong work experience in the pharmaceutical industry, spanning over several roles and companies. Lori is currently working as an Associate Director of Strategic Accounts at ADC Therapeutics since 2023. Prior to this, they worked as a Strategic Account Lead and a Rare Disease Specialist at Amryt Pharma from 2020 to the present. Lori also served as a Strategic Account Lead at Chiesi USA, Inc. from 2020 to 2023. In addition, they worked as a Territory Business Manager at Chiasma Pharma from 2020 to 2022. Before that, they held roles at Shire, Gilead Sciences, Actelion, Biogen, and Genentech, contributing to their diverse experience in disease education, business management, and institutional sales.

Lori Reiman holds a Bachelor of Science degree in Business Administration from Miami University. Additionally, they have obtained certifications in "Communicate to Influence (Blinkist Summary)" and "The Six Morning Habits of High Performers" from LinkedIn in 2021.